These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

446 related items for PubMed ID: 6177960

  • 41. Alpha 1-blockade for the treatment of hypertension: a megastudy of terazosin in 2214 clinical practice settings.
    Itskovitz HD.
    Clin Ther; 1994; 16(3):490-504. PubMed ID: 7923316
    [Abstract] [Full Text] [Related]

  • 42. Randomised two way crossover comparison of the effects of six weeks propranolol and acebutolol therapy on plasma lipid profiles in patients with hypertension or ischaemic heart disease.
    Tyagi S, Bhargava M, Bhattacharya J, Khalilullah M.
    Indian Heart J; 1990; 42(2):117-9. PubMed ID: 2081608
    [Abstract] [Full Text] [Related]

  • 43. Concomitant considerations in long-term antihypertensive treatment.
    Holzgreve H, Middeke M.
    J Hum Hypertens; 1990 Dec; 4 Suppl 5():11-8. PubMed ID: 2090833
    [Abstract] [Full Text] [Related]

  • 44. Effect of metabolic control of the serum lipid and lipoprotein levels on insulin-dependent diabetes mellitus.
    Romics L, Karádi I, Rozenberczki M, Kammerer L.
    Acta Med Acad Sci Hung; 1982 Dec; 39(3-4):117-23. PubMed ID: 6764327
    [Abstract] [Full Text] [Related]

  • 45. Effect of prazosin on serum lipids.
    Kokubu T, Itoh I, Kurita H, Ochi T, Murata K, Yuba I.
    J Cardiovasc Pharmacol; 1982 Dec; 4 Suppl 2():S228-32. PubMed ID: 6177962
    [Abstract] [Full Text] [Related]

  • 46. Effects of carvedilol on serum lipids in patients with essential hypertension.
    Goto Y, Tamachi H, Fusegawa Y, Nakaya N, Homma Y, Mikami M, Iori S, Yamazaki A.
    J Cardiovasc Pharmacol; 1991 Dec; 18 Suppl 4():S45-50. PubMed ID: 1721979
    [Abstract] [Full Text] [Related]

  • 47. Serum lipoproteins and ischemic vascular disease: on the interpretation of serum lipid versus serum lipoprotein concentrations.
    Rössner S.
    J Cardiovasc Pharmacol; 1982 Dec; 4 Suppl 2():S201-5. PubMed ID: 6177957
    [No Abstract] [Full Text] [Related]

  • 48. The effects of antihypertensive agents on serum lipids and lipoproteins.
    Lardinois CK, Neuman SL.
    Arch Intern Med; 1988 Jun; 148(6):1280-8. PubMed ID: 2897834
    [Abstract] [Full Text] [Related]

  • 49. Alpha 1-blockers, their antihypertensive efficacy and effects on lipids and lipoprotein.
    Kincaid-Smith P.
    J Hum Hypertens; 1989 Dec; 3 Suppl 2():75-83. PubMed ID: 2575178
    [Abstract] [Full Text] [Related]

  • 50. Effect of propranolol and prazosin on blood lipids. The Oslo Study.
    Leren P, Foss PO, Helgeland A, Hjermann I, Holme I, Lund-Larsen PG.
    Lancet; 1980 Jul 05; 2(8184):4-6. PubMed ID: 6104255
    [Abstract] [Full Text] [Related]

  • 51. Antihypertensive therapy and the risk of coronary heart disease.
    Ames RP, Hill P.
    J Cardiovasc Pharmacol; 1982 Jul 05; 4 Suppl 2():S206-12. PubMed ID: 6177958
    [Abstract] [Full Text] [Related]

  • 52. [Effect of anti-hypertensive treatment on plasma lipids and lipoproteins (author's transl)].
    Sauvanet JP, Rouffy J.
    Pathol Biol (Paris); 1981 Sep 05; 29(7):435-40. PubMed ID: 6117048
    [Abstract] [Full Text] [Related]

  • 53. Effects of a new alpha 1-blocker, bunazosin hydrochloride, on plasma lipid components in hypertensive patients with hypercholesterolemia.
    Yashiro A, Sugano M, Nakashima Y, Tasaki H, Kuroiwa A.
    Clin Ther; 1987 Sep 05; 10(1):98-106. PubMed ID: 2897239
    [Abstract] [Full Text] [Related]

  • 54. [Effect of anti-hypertensive treatment on plasma lipids and lipoproteins (author's transl)].
    Sauvanet JP, Rouffy J.
    Sem Hop; 1982 Mar 04; 58(9):563-8. PubMed ID: 6121378
    [Abstract] [Full Text] [Related]

  • 55. Prazosin: a review of clinical experience in hypertension.
    Packard RS.
    Ther Umsch; 1981 Mar 04; 38 Suppl():28-32. PubMed ID: 6122285
    [No Abstract] [Full Text] [Related]

  • 56. Effects of diltiazem hydrochloride on serum lipids: comparison with beta-blockers.
    Wada S, Nakayama M, Masaki K.
    Clin Ther; 1982 Mar 04; 5(2):163-73. PubMed ID: 6130841
    [Abstract] [Full Text] [Related]

  • 57. Effects of moduretic on plasma lipid and lipoprotein levels in hypertensive African patients.
    Ahaneku JE, Taylor GO, Agbedana OE, Walker O, Salako LA.
    Tokai J Exp Clin Med; 1993 Dec 04; 18(3-6):155-60. PubMed ID: 7701530
    [Abstract] [Full Text] [Related]

  • 58. Doxazosin: a new alpha 1-adrenergic antagonist.
    Babamoto KS, Hirokawa WT.
    Clin Pharm; 1992 May 04; 11(5):415-27. PubMed ID: 1349855
    [Abstract] [Full Text] [Related]

  • 59. Effects of arotinolol on serum lipid and apolipoprotein levels in patients with mild essential hypertension.
    Sasaki J, Handa K, Arakawa K.
    Clin Ther; 1989 May 04; 11(5):580-3. PubMed ID: 2478285
    [Abstract] [Full Text] [Related]

  • 60. [Interference with lipid metabolism by various antihypertensive agents: facts and hypotheses].
    Rouffy J.
    Arch Mal Coeur Vaiss; 1987 Apr 04; 80 Spec No():43-6. PubMed ID: 2887148
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.